TGA Approval

VITRAKVI larotrectinib (as sulfate) 25 mg hard capsule bottle (320237)

ARTG ID

320237

ARTG Name

VITRAKVI larotrectinib (as sulfate) 25 mg hard capsule bottle

Sponsor

Bayer Australia Ltd

ARTG Date

September 7, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered - Prescription

Sponsor Information

Sponsor Name

Sponsor Item Name

BAYER AUSTRALIA LTD

https://medical-cdn.nocode.com/drug_tga/74e3eb8086e1935a5eeaa55dc9f05654.pdf

https://medical-cdn.nocode.com/drug_tga/91c2ee80844939c64859343d93ff25a3.pdf

Ingredient Name

larotrectinib sulfate

Empowering clinical research with data-driven insights and AI-powered tools.

VITRAKVI larotrectinib (as sulfate) 25 mg hard capsule bottle (320237) - TGA 批准文号 | MedPath